Relationship between perlecan and tropoelastin gene expression and cell replication in the developing rat pulmonary vasculature

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 1, 1999, Pages 24-34

  Belknap, James K ^a   Weiser Evans, Mary C M ^a   Grieshaber, Scott S ^a   Majack, Richard A ^a   Stenmark, Kurt R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILEX COOKII;

BROXURIDINE; DNA; HEPARAN SULFATE; MESSENGER RNA; PERLECAN; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; TROPOELASTIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL DIVISION; CYTOLOGY; FEMALE; GENE EXPRESSION; GENETICS; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; MUSCLE DEVELOPMENT; PREGNANCY; PRENATAL DEVELOPMENT; PULMONARY ARTERY; RAT; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BROMODEOXYURIDINE; CELL DIVISION; DNA; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MUSCLE DEVELOPMENT; MUSCLE, SMOOTH, VASCULAR; PREGNANCY; PROTEOGLYCANS; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TISSUE DISTRIBUTION; TROPOELASTIN;

EID: 0032615711     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.1.3321     Document Type: Article

References (69)

1. Stenmark, K. R., and R. P. Mecham. 1997. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu. Rev. Physiol. 59:89-144.
2. deMello, D. E., D. Sawyer, N. Galvin, and L. M. Reid. 1997. Early fetal development of lung vasculature. Am. J. Respir. Cell Mol. Biol 16:568-581.
3. Hungerford, J. E., G. K. Owens, W. S. Argraves, and C. D. Little. 1996. Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev. Biol. 170:375-392.
4. Cook, C. L., M. C. M. Weiser, P. E. Schwartz, C. L. Jones, and R. A. Majack. 1994. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ. Res. 74:189-196.
5. Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25.
6. Ruoslahti, E. 1989. Proteoglycans in cell regulation. J. Biol. Chem. 264: 13369-13372.
7. Wight, T. N., M. G. Kinsella, and E. E. Qwarnstrom. 1992. The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin. Cell Biol. 4:793-801.
8. Adams, J. C., and F. M. Watt. 1993. Regulation of development and differentiation by the extracellular matrix. Development 117:1183-1198.
9. Thyberg, J., and A. Hulrgardh-Nilsson. 1994. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res. 276:263-271.
10. Sui, G. J., Y. H. Liui, X. S. Cheng, I. S. Anand, E. Harris, P. L. Harris, and D. Heath. 1988. Subacute infantile mountain sickness. J. Pathol. 155:161-170.
11. Haworth, S. G. 1988. Pulmonary vascular remodeling in neonatal pulmonary hypertension. State of the art. Chest 93:133S-136S.
12. Haworth, S. G., and L. Reid. 1976. Persistent fetal circulation: newly recognized structural features. J. Pediatr. 88:614-620.
13. Mecham, R. P., L. A. Whitehouse, D. S. Wrenn, W. C. Parks, G. L. Griffin, R. M. Senior, E. C. Crouch, K. R. Stenmark, and N. F. Voelkel. 1987. Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science 237:423-426.
14. Lipke, D. W., S. S. Arcot, M. N. Gillespie, and J. W. Olson. 1993. Temporal alterations in specific basement membrane components in lungs from monocrotaline-treated rats. Am. J. Respir. Cell Mol. Biol. 9:418-428.
15. Todorovich-Hunter, L., D. J. Johnson, P. Ranger, F. W. Keeley, and M. Rabinovitch. 1988. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline: a biochemical study. Lab. Invest. 58:184-195.
16. Durmowicz, A. G., W. C. Parks, D. M. Hyde, R. P. Mecham, and K. R. Stenmark. 1994. Persistence, re-expression, and induction of pulmonary arterial fibronectin, tropoelastin, and type I procollagen mRNA expression in neonatal hypoxic pulmonary hypertension. Am. J. Pathol. 145: 1411-1420.
17. Stenmark, K. R., A. G. Durmowicz, J. D. Roby, R. P. Mecham, and W. C. Parks. 1994. Persistence of the fetal pattern of tropoelastin gene expression in severe neonatal bovine pulmonary hypertension. J. Clin. Invest. 93:1234-1242.
18. Weiser, M. C. M., N. A. Grieshaber, P. E. Schwartz, and R. A. Majack. 1997. Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells. Mol. Biol. Cell 8:999-1011.
19. Li, X., P. Tsai, E. D. Weider, A. Kribben, V. Van Putten, R. W. Schrier, and R. A. S. Nemenoff. 1994. Vascular smooth muscle cells grown on Matrigel: a model of the contractile phenotype with decreased activation of mitogen-activated protein kinase. J. Biol. Chem. 265:19653-19658.
20. Pauly, R. R., A. Passaniti, M. Crow, J. L. Kinsella, N. Papadopoulos, R. Monticone, E. G. Ladatta, and G. R. Martin. 1992. Experimental models that mimic the differentiation and dedifferentiation of vascular cells. Circulation 86(Suppl. 3):68-73.
21. Couchman, J. R. 1987. Heterogenous distribution of a basement membrane heparan sulfate proteoglycan in rat tissues. J. Cell Biol. 105:1901-1916.
22. Murdoch, A. D., B. Liu, R. Schwarting, R. S. Tuan, and R. V. Iozzo. 1994. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem. 42:239-249.
23. Iozzo, R. V., I. R. Cohen, S. Grassel, and A. D. Murdoch. 1994. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 302:625-639.
24. Sannes, P. L., and J. Wang. 1997. Basement membranes and pulmonary development. Exp. Lung Res. 23:101-108.
25. Benitz, W. E., R. T. Kelley, C. M. Anderson, D. E. Lorant, and M. Bernfield. 1990. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. Am. J. Respir. Cell Mol. Biol. 2:13-24.
26. Sekiguchi, R. T., S. Potter-Perigo, K. Braun, J. Miller, C. Ngo, K. Fukuchi, T. N. Wight, K. Kimata, and A. D. Snow. 1994. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation. J. Neurosci. Res. 38:670-686.
27. Campbell, J. H., R. E. Rennick, S. G. Kalevitch, and G. R. Campbell. 1992. Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype. Exp. Cell Res. 200:156-167.
28. Partridge, S. M. 1962. Elastin. Adv. Protein Chem. 17:227-302.
29. Noguchi, A., and H. Samaha. 1991. Developmental changes in tropoelastin gene expression in the rat lung studied by in situ hybridization. Am. J. Respir. Cell Mol. Biol. 5:571-578.
30. Noguchi, A., R. L. Reddy, J. D. Kursar, W. C. Parks, and R. P. Mecham. 1989. Smooth muscle isoactin and elastin in fetal bovine lung. Exp. Lung Res. 15:537-552.
31. Davidson, J. M., S. Shibahara, C. Boyd, M. L. Mason, P. Tolstoshev, and R. G. Crystal. 1984. Elastin mRNA levels during fetal development of sheep nuchal ligament and lung. Biochem. J. 220:653-663.
32. Powell, J. T., and P. L. Whitney. 1980. Changes in lung lectin, elastin, acetylcholinesterase and other enzymes. Biochem. J. 188:1-8.
33. Myers, B., M. Dubick, J. A. Last, and R. B. Rucker. 1983. Elastin synthesis during perinatal lung development in the rat. Biochim. Biophys. Acta 761: 17-22.
34. Davidson, J. M., K. E. Hill, and J. L. Alford. 1986. Developmental changes in collagen and elastin biosynthesis in the porcine aorta. Dev. Biol. 118: 103-111.
35. Belknap, J. K., N. A. Grieshaber, P. E. Schwartz, E. C. Orton, M. A. Reidy, and R. A. Majack. 1996. Tropoelastin gene expression in individual vascular smooth muscle cells: relationship to DNA synthesis during vascular development and after arterial injury. Circ. Res. 78:388-394.
36. Clowes, A. W., M. A. Reidy, and M. M. Clowes. 1983. Kinetics of cellular proliferation after arterial injury I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49:327-333.
37. Weiser, M. C. M., J. K. Belknap, S. S. Grieshaber, M. G. Kinsella, and R. A. Majack. 1996. Developmental regulation of perlecan gene expression in aortic smooth muscle cells. Matrix Biol. 15:331-340.
38. Hassell, J. R., P. G. Robey, H. J. Barrach, J. Wilczek, S. I. Rennard, and G. R. Martin. 1980. Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc. Natl. Acad. Sci. USA 77:4494-4498.
39. Belknap, J. K., E. C. Orton, B. Ensley, A. Tucker, and K. R. Stenmark. 1997. Hypoxia increases bromodeoxyuridine labeling indices in bovine neonatal pulmonary arteries. Am. J. Respir. Cell Mol. Biol. 16:366-371.
40. Xu, Y., K. R. Stenmark, M. Das, S. J. Walchak, L. J. Ruff, and E. C. Dempsey. 1997. Pulmonary artery smooth muscle cells from chronically hypoxic neonatal calves retain fetal-like and acquire new growth properties. Am. J. Physiol. 273:L234-L245.
41. Hershenson, M. B., M. D. Kelleher, E. T. Naureckas, M. K. Abe, V. J. Rubinstein, A. Zimmermann, A. M. Bendele, J. A. McNulty, R. A. Panettieri, and J. Solway. 1994. Hyperoxia increases airway cell S-phase traversal in immature rats in vivo. Am. J. Respir. Cell Mol. Biol. 11:296-303.
42. Kallunki, P., and K. Tryggvason. 1992. Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Cell Biol. 116:559-571.
43. Aviezer, D., D. Hecht, M. Safran, M. Eisinger, G. David, and A. Yayon. 1994. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79:1005-1013.
44. Murdoch, A. D., B. Liu, R. Scwarting, R. S. Tuan, and R. V. Iozzo. 1994. Widespread expression of perlecan proteoglycan in basement membranes as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem. 42:239-249.
45. Lipke, D. W., K. J. McCarthy, T. S. Elton, S. A. Santosh, S. Oparil, and J. R. Couchman. 1993. Coarctation induces alterations in basement membranes in the cardiovascular system. Hypertension 22:743-753.
46. Murdoch, A. D., G. R. Dodge, I. Cohen, R. S. Tuan, and R. V. Iozzo. 1992. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Biol. Chem. 267:8544-8557.
47. Hayashi, K., J. A. Madri, and P. D. Yurchenco. 1992. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan. J. Cell Biol. 119:945-959.
48. Yamagata, M., S. Saga, M. Kato, M. Bernfield, and K. Kimata. 1993. Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. J. Cell Sci. 106:55-65.
49. Clowes, A. W., and M. M. Clowes. 1985. Kinetics of cellular proliferation after arterial injury: II. Inhibition of smooth muscle growth by heparin. Lab. Invest. 52:611-616.
50. Pukac, L. A., M. E. Ottlinger, and M. J. Karnovsky. 1993. Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J. Biol. Chem. 267:3707-3711.
51. Ottlinger, M. E., L. A. Pukac, and M. J. Karnovsky. 1993. Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J. Biol. Chem. 268:19173-19176.
52. Pukac, L. A., J. J. Catellot, Jr., T. C. Wright, Jr., B. L. Caleb, and M. J. Karnovsky. 1990. Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regul. 1:435-443.
53. Lindner, V., N. E. Olson, A. W. Closes, and M. A. Reidy. 1992. Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J. Clin. Invest. 90:2044-2099.
54. Au, Y. P., G. Doabrowolska, D. R. Morris, and A. W. Clowes. 1994. Heparin decreases activator protein-1 binding to DNA in part byposttranslational modification of Jun B. Circ. Res. 75:15-22.
55. Majack, R. A., S. C. Cook, and P. Bornstein. 1986. Regulation of smooth muscle cell growth by components of the extracellular matrix: an autocrine role for thrombospondin. Proc. Natl. Acad. Sci. USA 83:9050-9054.
56. Kenagy, R. D., S. T. Nikkari, H. G. Welgus, and A. W. Clowes. 1994. Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. J. Clin. Invest. 93:1987-1993.
57. Clowes, A. W., M. M. Clowes, T. R. Kirkman, C. L. Jackson, Y. P. Au, and R. Kenagy. 1992. Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery. Circ. Res. 70:1128-1136.
58. Au, Y. P., R. D. Kenagy, and A. W. Clowes. 1992. Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis. J. Biol. Chem. 267:3438-3444.
59. Cohen, I. R., A. D. Murdoch, M. F. Naso, D. Marchetti, D. Berd, and R. V. Iozzo. 1994. Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res. 54:5771-5774.
60. Nikkari, S. T., H. T. Jarvelainen, T. N. Wight, M. Ferguson, and A. W. Clowes. 1994. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am. J. Pathol. 144:1348-1355.
61. Thompson, B. T., C. R. Spence, S. P. Janssens, P. M. Joseph, and C. A. Hales. 1994. Inhibition of hypoxic pulmonary hypertension by heparins of differing in vitro antiproliferative potency. Am. J. Crit. Care Med. 149: 1512-1517.
62. Hassoun, P. M., B. T. Thompson, and C. A. Hales. 1992. Partial reversal of hypoxic pulmonary hypertension by heparin. Am. Rev. Respir. Dis. 145: 193-196.
63. Spence, C. R., B. T. Thompson, S. P. Janssens, D. M. Steigman, and C. A. Hales. 1993. Effect of aerosol heparin on the development of hypoxic pulmonary hypertension in the guinea pig. Am. Rev. Respir. Dis. 148:121-124.
64. Carson, D. D., J. P. Tang, and J. Julian. 1993. Heparan sulfate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence. Dev. Biol. 155:97-106.
65. Rosenbloom, J., W. R. Abrams, and R. Mecham. 1993. Extracellular matrix 4: the elastic fiber. FASEB J. 7:1208-1218.
66. Stenmark, K. R., J. Fasules, D. M. Hyde, N. F. Voelkel, J. Henson, A. Tucker, H. Wilson, and J. T. Reeves. 1987. Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m. J. Appl. Physiol. 62:821-830.
67. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 362:801-809.
68. Noguchi, A. H., and H. Samaha. 1991. Developmental changes in tropoelastin gene expression in the rat lung studied by in situ hybridization. Am. J. Respir. Cell Mol. Biol. 5:571-578.
69. Nardell, E. A., and J. S. Brody. 1982. Determinants of mechanical properties of rat lung during postnatal development. J. Appl. Physiol. (Respir. Environ. Exerc. Physiol.) 53:140-148.